| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |